Edwards Lifesciences valuation
Valuation
The P/E ratio is 61.6. The average price target of 27 analysts is $113.39.
Data as of November 17, 2026
Edwards Lifesciences compared with similar companies
Edwards Lifesciences's P/E (trailing 12 months): 61.6, +102% against the median of a group of 11 similar companies (30.5).
| Metric | Edwards Lifesciences | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| P/E (trailing 12 months) | 61.6 | 30.5 | 24.4 – 36.6 | High |
| Forward P/E | 31.6 | 18.4 | 15.4 – 23.4 | High |
| EV/EBITDA | 27.6 | 16.1 | 14.0 – 19.3 | High |
| Price/book | 5.68 | 3.65 | 2.90 – 6.03 | Middle |
| Price/sales | 9.23 | 3.86 | 3.08 – 5.23 | High |
| Gross margin | 78.0% | 65.7% | 60.3% – 68.7% | High |
| Operating margin | 28.8% | 19.2% | 16.2% – 22.0% | High |
| Net margin | 15.3% | 13.4% | 10.0% – 14.6% | High |
| ROE | 9.3% | 11.6% | 10.0% – 18.0% | Low |
| Debt/equity | 0.06 | 0.55 | 0.37 – 0.63 | Low |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Edwards Lifesciences: valuation over time
On the latest fiscal year's earnings (2025), Edwards Lifesciences's P/E today is 58.4, above the median of its last 8 fiscal years (45.9; between 10.6 and 70.2 from 2018 to 2025). Relative to earnings, the stock costs more than it used to.
| Fiscal year | Price at year end | Earnings per share | P/E |
|---|---|---|---|
| 2025 | $85.25 | $1.83 | 46.6 |
| 2024 | $74.03 | $6.97 | 10.6 |
| 2023 | $76.25 | $2.30 | 33.2 |
| 2022 | $74.61 | $2.44 | 30.6 |
| 2021 | $129.55 | $2.38 | 54.4 |
| 2020 | $91.23 | $1.30 | 70.2 |
| 2019 | $77.76 | $1.64 | 47.4 |
| 2018 | $51.06 | $1.13 | 45.2 |
TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only). Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above.
TickerLandia analysisHow it is calculated
Other metrics
Valuation multiples
- Market cap
- $61.59B
- Enterprise value
- $57.75B
- PEG
- 2.36
- EV/revenue
- 8.65
Profitability and growth
- ROA
- 8.8%
- Revenue growth (year over year)
- 10.5%
- Earnings growth (year over year)
- 6.7%
Financial health
- Total cash
- $4.64B
- Total debt
- $704.5M
- Current ratio
- 4.60
- Quick ratio
- 3.54
Dividends
- Dividend yield
- 0.0%
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- $113.39
- Median price target
- $115.00
- High price target
- $126.00
- Low price target
- $84.00
- Analysts with a price target
- 27
- Consensus
- Buy
- Forward EPS
- $3.39
- EPS estimate, current year
- $3.01
Shares and trading
- Beta
- 0.83
- Average volume
- 3.82M
- Shares outstanding
- 575M
- Float
- 573.22M
- Institutional ownership
- 95.2%
- Insider ownership
- 0.4%
- Short interest (% of float)
- 1.9%
- Short ratio (days)
- 2.58
